Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toxin Models of Mitochondrial Dysfunction in Parkinson's Disease
Terina N. Martinez, J. Timothy Greenamyre
Antioxidants and Redox Signaling (2011) Vol. 16, Iss. 9, pp. 920-934
Open Access | Times Cited: 244

Showing 1-25 of 244 citing articles:

Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.
George DeMaagd, Ashok Philip
PubMed (2015) Vol. 40, Iss. 8, pp. 504-32
Closed Access | Times Cited: 500
Mitochondria as a Target of Environmental Toxicants
Joel N. Meyer, Maxwell C. K. Leung, John P. Rooney, et al.
Toxicological Sciences (2013) Vol. 134, Iss. 1, pp. 1-17
Open Access | Times Cited: 500
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Laurie H. Sanders, J. Timothy Greenamyre
Free Radical Biology and Medicine (2013) Vol. 62, pp. 111-120
Open Access | Times Cited: 320
Protecting the mitochondrial powerhouse
Morten Scheibye‐Knudsen, Evandro Fei Fang, Deborah L. Croteau, et al.
Trends in Cell Biology (2014) Vol. 25, Iss. 3, pp. 158-170
Open Access | Times Cited: 295
An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene–environment interactions
Michaela Johnson, Larisa Bobrovskaya
NeuroToxicology (2014) Vol. 46, pp. 101-116
Closed Access | Times Cited: 290
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Edward O. Olufunmilayo, Michelle B. Gerke-Duncan, R. M. Damian Holsinger
Antioxidants (2023) Vol. 12, Iss. 2, pp. 517-517
Open Access | Times Cited: 267
Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease
Souvarish Sarkar, Emir Malovic, Dilshan S. Harishchandra, et al.
npj Parkinson s Disease (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 233
Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance
Sophia Raefsky, Mark P. Mattson
Free Radical Biology and Medicine (2016) Vol. 102, pp. 203-216
Open Access | Times Cited: 227
Neuroimmunological Processes in Parkinson's Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
Vanesa Sánchez-Guajardo, Christopher J. Barnum, Malú G. Tansey, et al.
ASN NEURO (2013) Vol. 5, Iss. 2, pp. AN20120066-AN20120066
Open Access | Times Cited: 221
Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
Yaping Shao, Weidong Le
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 208
Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
Shannon Rose, Dmitriy Niyazov, Daniel A. Rossignol, et al.
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 5, pp. 571-593
Open Access | Times Cited: 200
Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?
Ruby I. MacDonald, Katy Barnes, Christopher Hastings, et al.
Biochemical Society Transactions (2018) Vol. 46, Iss. 4, pp. 891-909
Open Access | Times Cited: 190
Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies
Anna Villar‐Piqué, Tomás Lopes da Fonseca, Tiago F. Outeiro
Journal of Neurochemistry (2015) Vol. 139, Iss. S1, pp. 240-255
Open Access | Times Cited: 189
Efficient Mitochondrial Genome Editing by CRISPR/Cas9
Areum Jo, Sangwoo Ham, Gum Hwa Lee, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-10
Open Access | Times Cited: 183
Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease
Sahabuddin Ahmed, Mohit Kwatra, Samir Ranjan Panda, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 142-158
Closed Access | Times Cited: 161
Advancement in the modelling and therapeutics of Parkinson’s disease
Sachchida Nand, Payal Singh
Journal of Chemical Neuroanatomy (2020) Vol. 104, pp. 101752-101752
Closed Access | Times Cited: 160
The Biosynthesis, Signaling, and Neurological Functions of Bile Acids
Yoshimitsu Kiriyama, Hiromi Nochi
Biomolecules (2019) Vol. 9, Iss. 6, pp. 232-232
Open Access | Times Cited: 153
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Martin T. Henrich, Wolfgang H. Oertel, D. James Surmeier, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 87
Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 75
Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells
Felipe A. Bustamante-Barrientos, Noymar Luque‐Campos, María Jesús Araya, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
Laurie H. Sanders, Jennifer L. McCoy, Xiao Hu, et al.
Neurobiology of Disease (2014) Vol. 70, pp. 214-223
Open Access | Times Cited: 173
Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases
Niamh M. C. Connolly, Pierre Theurey, Vera Ádám‐Vizi, et al.
Cell Death and Differentiation (2017) Vol. 25, Iss. 3, pp. 542-572
Open Access | Times Cited: 155
A Mitocentric View of Parkinson's Disease
Nele A. Haelterman, Wan Hee Yoon, Héctor Sandoval, et al.
Annual Review of Neuroscience (2014) Vol. 37, Iss. 1, pp. 137-159
Open Access | Times Cited: 140
Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism
Annadurai Anandhan, Maria S. Jacome, Shulei Lei, et al.
Brain Research Bulletin (2017) Vol. 133, pp. 12-30
Open Access | Times Cited: 138
A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
Shams Tabrez, Nasimudeen R. Jabir, Shazi Shakil, et al.
CNS & Neurological Disorders - Drug Targets (2012) Vol. 11, Iss. 4, pp. 395-409
Open Access | Times Cited: 132
Page 1 - Next Page

Scroll to top